• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

IDEX Corporation Completes Acquisition of Abel Pumps, L.P.

Share:

March 15, 2021

IDEX Corporation (NYSE:IEX) today completed its previously announced acquisition of Abel Pumps, L.P., and certain of its affiliates (ABEL) from Hillenbrand, Inc. (NYSE: HI).

ABEL designs and manufactures highly engineered reciprocating positive displacement pumps for a variety of end markets, including mining, marine, power, water, wastewater and other general industries. The company’s diaphragm and high-pressure piston pumps serve harsh, demanding applications involving abrasive or corrosive substances and fluids with high solids content.

“We welcome ABEL and its employees worldwide to the IDEX family of businesses. We look forward to their expertise complementing the longstanding strength IDEX has in pump and valve manufacturing,” IDEX Chief Executive Officer and President Eric Ashleman said. “As part of our great team, together we will further expand our abilities to solve customers’ toughest fluidics challenges.”

ABEL’s administration office and manufacturing plant are in Büchen, Germany, with sales and service locations in Madrid and Pittsburgh. ABEL joins IDEX’s Fluid and Metering Technologies segment.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Healthcare Needs AI, AI Needs CausalityHealthcare Needs AI, AI Needs Causality
  • Solvias Completes Agreement with Strategic Healthcare Investors to Advance ExpansionSolvias Completes Agreement with Strategic Healthcare Investors to Advance Expansion
  • Global Azithromycin Drug Market (BASED ON 2020 COVID-19 WORLDWIDE SPREAD) Research Report Delivers Valuable Insights And The Credibility, 2020-2025Global Azithromycin Drug Market (BASED ON 2020 COVID-19 WORLDWIDE SPREAD) Research Report Delivers Valuable Insights And The Credibility, 2020-2025
  • Why Clinical Trial Design Can Make or Break Your CompanyWhy Clinical Trial Design Can Make or Break Your Company
  • FSD Pharma still interested in synthetic cannabinoidFSD Pharma still interested in synthetic cannabinoid
  • Medical Properties Trust Announces Public Offering of $750.0 Million of Senior Notes Due 2029Medical Properties Trust Announces Public Offering of $750.0 Million of Senior Notes Due 2029
  • Fitbit, FibriCheck Expand Partnership to Deliver CE-Marked Heart Health Detection App in EuropeFitbit, FibriCheck Expand Partnership to Deliver CE-Marked Heart Health Detection App in Europe
  • 83% of Consumers Would Feel Safer in Hospitals with COVID-19 Contact Tracing Technology, Survey Reveals83% of Consumers Would Feel Safer in Hospitals with COVID-19 Contact Tracing Technology, Survey Reveals

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications